China's medical products administrator approved MicroPort CardioFlow Medtech's (HKG:2160) registration for its transcatheter aortic valve implantation product, according to a Tuesday filing with the Hong Kong Exchange.
The product, branded VitaFlow Liberty, helps the valve maintain coaxial alignment during deployment of the valve, the filing said.